IFNL3 and steatosis: Recent findings on the role of genetic variants associated with different responses to interferon-based treatment, the single-nucleotide polymorphisms near the IL28B gene, shed further light on the pathogenetic mechanism of steatosis in HCV infection, suggesting that different genetic backgrounds may be conditions for the development of steatosis regardless of the genotype in HCV-infected subjects.